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IT has  recently  been  reported  that  phycocyanin,  a
biliprotein found in the blue–green microalgae Spir-
ulina, exerts anti-inflammatory effects in some ani-
mal  models  of  inflammation.  Taking  into  account
these  findings,  we  decided  to  elucidate  whether
phycocyanin might exert also inhibitory effects in the
induced allergic inflammatory response and on hista-
mine release from isolated rat mast cells. In in vivo
experiments, phycocyanin (100, 200 and 300mg/kg
post-orally  (p.o.))  was  administered  1h  before the
challenge with 1m g of ovalbumin (OA) in the ear of
mice previously sensitized with OA. One hour later,
myeloperoxidase  activity  and  ear  edema  were
assessed.  Phycocyanin  significantly  reduced  both
parameters.  In  separate  experiments,  phycocyanin
(100 and 200mg/kg p.o.) also reduced the blue spot
area induced by intradermal injections of histamine,
and the histamine releaser compound 48/80  in rat
skin. In concordance with the former results, phyco-
cyanin also significantly  reduced histamine release
induced by compound 48/80 from isolated peritoneal
rat mast cells. The inhibitory effects of phycocyanin
were  dose  dependent.  Taken  together,  our  results
suggest  that  inhibition  of  allergic  inflammatory
response by phycocyanin is mediated, at least in part,
by inhibition of histamine release from mast cells.
Key  words:  Phycocyanin,  Inhibition,  Histamine  release,
Allergic inflammatory response, Rat mast cells
Introduction
We recently reported that phycocyanin, a biliprotein
found in the blue–green microalgae Spirulina exerts
antioxidative and anti-inflammatory effects in various
in  vitro and  in  vivo experimental  models.1 These
effects  are  mediated  by  the  scavenging  action  of
phycocyanin against reactive oxygen  species (ROS)
such  as  OH￿,  RO￿ and  RO2,  anti-lipoperoxidative
activity, and inhibitory effects on prostaglandin and
leukotriene  biosynthesis.2,3 Recently,  an  inhibitory
effect of Spirulina on mast cell-mediated immediate-
type  allergic  reactions in  rats  has  also  been  repor-
ted.4 Thus,  taking into account the former findings
and  the  fact  that  phycocyanin  accounts  for  more
than  20%  of  algae  dry  weight,  we  decided  to
elucidate whether or not both allergic inflammatory
response and  histamine  release  from  rat mast cells
are inhibited by phycocyanin.
Materials and methods
Chemicals
Ovalbumin, o-dianisidine and compound 48/80 were
purchased  from  Sigma  (St  Louis,  MO,  USA).
Orthophthalaldehyde was obtained from Merck (Bar-
celona, Spain).
Other reagents of analytical grade were purchased
from normal commercial sources.
Preparation of phycocyanin extract
Phycocyanin was extracted from  microalgae  Artho-
spira maxima as described in a Cuban patent.5 The
blue  powder  thus  obtained  showed  a  peak  in  the
visible absorption spectrum of 617nm, which is very
close to that reported for c-phycocyanin.6
Animals
Male  Balb/c  mice  (20–25g)  and  male  Sprague–
Dawley  rats  (175–250g)  were  obtained  from  the
breeding colony of the National Center for Laboratory
Animal Production (CENPALAB, Havana, Cuba). The
animals were housed under a 12h light–dark cycle
with room temperature maintained at 25°C, humidity
at 60%, and food and water available ad libitum.The
experiments were conducted in accordance with the
ethical  guidelines  for  investigations  in  laboratory
animals and were approved by the Ethical Committee
for Animal Experimentation of the National Center for
Scientific Research.
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response to ovalbumin
This test was carried out as described by Hessel et al.7
Active  sensitization  was  performed  by  seven  intra-
peritoneal injections of 10mg of ovalbumin in 0.5ml
of  saline  on  alternate  days.  A  group  of  animals
received injections with saline only.
Four weeks after the last injection, the mice were
divided into groups of seven animals and treated by
gavage with phycocyanin (100, 200 and 300mg/kg),
with  triamcinolone  (10mg/kg)  used  as  a  reference
drug  or  saline.  One  hour  later,  the  animals  were
challenged intracutaneously with 1mg of ovalbumin
in 0.01ml of saline on the right ear and saline only on
the left ear. Inflammation was followed for 1h and
thereafter animals were killed by cervical dislocation.
A 6mm  diameter disc from  each ear  was  removed
with  a  metal  punch  and  weighed.  The  swelling
induced by ovalbumin was assessed as the increase in
the weight of the right ear punch biopsy over that of
the left ear and was called the edema index.
Determination of myeloperoxidase activity
Tissue samples were assessed biochemically for the
neutrophil marker enzyme myeloperoxidase (MPO),
using the method of Bradley et al.8 All the ear tissue
was homogenized in 50 mM K2HPO4/KH2PO4 buffer
(pH 6) containing 0.5% hexadecyl trimethylammon-
ium  bromide  using  a  polytron  (Ultra  turrax  x-25)
homogenizer. After freeze–thawing three times, the
samples were centrifuged at 2500 ´ g for 30min at
4°C  and  aliquots  of  the  supernatant  assayed  spec-
trophotometrically for MPO. In brief, 40ml of sample
was mixed with 960ml of 50 mM phosphate buffer
(pH 6) containing 0.167mg/ml of o-dianisidine dihy-
drochloride  and  0.0005%  hydrogen  peroxide.  The
change in absorbance at 460nm was measured with a
Spekol 220 spectrophotometer (Carl Zeiss, Germany).
MPO activity data are presented as units per milligram
of tissue. One unit of MPO activity was defined as that
degrading  one micromole  of  hydrogen peroxide to
water per minute at 25°C.
Skin reactions to histamine and compound
48/80 in rats
The method described by Awouters et al.9 was used.
Groups of five rats were pre-treated with phycocyanin
(50, 100 and 200mg/kg per-orally (p.o.)), saline and
promethazine (25mg/kg) as positive control.
One hour thereafter, the animals were injected by
duplicate into the shaved dorsal skin with histamine
(50mg) and the histamine releaser compound 48/80
(50mg),  and  immediately  afterwards  also  injected
intravenously  with  1ml  of  0.4%  Evans  blue  dye
dissolved in saline.
After 30min, the rats were euthanized, skinned and
the  positive  blue  skin  reactions  were  measured  to
determine their area.
Histamine release from isolated rat peritoneal
mast cells
Experiments were performed using mixed peritoneal
cells  of  the  rat  (1–5%  mast  cells)  prepared  as
described by Garland and Mongar.10
The peritoneal washings from at least five rats were
pooled and kept on ice until used. The washings were
centrifuged at 250 ´ g for 6min, the supernatant was
discarded  and  the  cell  pellet  resuspended  in  cold
Tyrode  solution  (3ml  per  rat)  of  the  following
composition:  NaCl,  137 mM;  NaHCO3,  12 mM;
NaH2PO4,  0.3 mM;  KCl,  2.7 mM;  MgCl2,  1 mM;
CaCl2, 1.8 mM; dextrose, 5.6 mM.
The cell suspension (0.5ml aliquots in duplicate)
was  pre-incubated  at  37°C  for  10min  with  three
concentrations  of  phycocyanin  (3,  5  and  8mg/ml)
and  stimulated for a further 5min  with  compound
48/80 (1mg/ml). The reaction was then stopped by
placing  the tubes  in  an ice bath. Each sample was
centrifuged at 250 ´ g for 6min, the supernatant was
decanted,  and  the  pellets  resuspended  in  1ml  of
Tyrode  solution  and  boiled  for  10min  to  release
residual  histamine.  Release  and  residual  histamine
were measured fluorimetrically.11
The  results  are  expressed  as  the  percentage  of
histamine  released  from  the  total  content  of  mast
cells. Histamine release values were corrected for a
spontaneous release of  between 2 and 8%. Prelimi-
nary assays demonstrated that phycocyanin did not
interfere with fluorimetric histamine determination.
Statistical analysis
Data are presented as mean ± SEM. Mean differences
between groups were compared by one-way analysis
of  variance  with  the  Duncan  multi-range  test.  In
experiments with rat peritoneal mast cells, Student’s
t-test  was  used  to  make  a  statistical  comparison
between  the  mean  values.  The  level  of  statistical
significance was taken as p < 0.05.
Results
Effects of phycocyanin on mouse ear swelling
response to ovalbumin
One  hour  after  ovalbumin  challenge,  a  marked
increase in both ear thickness (4.70 ± 0.16mg) and
MPO  activity  (3.13  ±  0.21U/mg  of  tissue)  were
observed in ovalbumin-sensitized mice (Table 1). Pre-
treatment with phycocyanin (100, 200 and 300mg/kg
p.o.)  1h  before  ovalbumin  challenge  significantly
inhibited ear edema and MPO activity in this model.
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dependent. Triamcinolone  (10mg/kg)  also  induced
remarkable  reduction  on  edema  index  and  MPO
activity (Table 1).
Effect of phycocyanin on skin reactions
induced by intradermal injections of histamine
and compound 48/80 in rats
Pre-treatment with phycocyanin (100 and 200mg/kg
p.o.)  significantly  inhibited,  in  a  dose-dependent
manner,  the  skin  reactions  induced  by  compound
48/80 and histamine. The lower dose of phycocyanin
(50mg/kg)  did  not  induce  significant  inhibitory
effect. The  histamine  H1-receptor  antagonist  prom-
ethazine (25mg/kg) produced a strong inhibition of
skin  reaction  induced  by  compound  48/80  and
histamine (Fig. 1).
Effect of phycocyanin on histamine release
from isolated rat peritoneal mast cells
Phycocyanin (3, 5, and 8mg/ml) significantly inhibited
compound 48/80-induced histamine release from rat
peritoneal mast cells following 10min pre-incubation.
The inhibitory effect of phycocyanin was concentra-
tion dependent (Fig. 2).
Discussion
Increased microvascular permeability to plasma pro-
teins  is  one  of  the  characteristic  features  of  the
allergic inflammatory response. Mast cells are recog-
nized to play a crucial role in allergen-induced plasma
leakage because they can release pre-formed vasoac-
tive mediators, among which the role of  histamine
and, in the case of rats and mice also of serotonin, has
been historically emphasized.12,13
More  recently,  it  has  been  demonstrated  that,
besides  the  former  vasoactive  amines,  mast  cells
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Table 1. Effect of phycocyanin on mouse ear swelling response to ovalbumin
Treatment Edema index
(mg)
Inhibition
(%)
MPO
(U/mg of tissue)
Inhibition
(%)
Saline (non-sensitized) 0.15 ± 0.05* – 0.14 ± 0.05* –
Ovalbumin controls 4.70 ± 0.16* – 3.13 ± 0.21 –
Triamcinolone (10mg/kg) 0.25 ± 0.05* 98 0.23 ± 0.09* 93
Phycocyanin (100mg/kg) 3.80 ± 0.43* 19 2.45 ± 0.46* 22
Phycocyanin (200mg/kg) 2.28 ± 0.19* 52 1.51 ± 0.24* 52
Phycocyanin (300mg/kg) 1.78 ± 0.40* 62 1.07 ± 0.14* 66
Values are expressed as mean ± SEM. Ten mice per group. The edema index was assessed as the increase in the weight of the right ear punch
biopsy over that of the left ear. Edema was measured 1h after ovalbumin challenge.
*p < 0.05, statistically significant with respect to ovalbumin control group.
FIG. 1. Effects of phycocyanin and promethazine on hista-
mine and compound 48/80-induced cutaneous reactions in
rats. Phycocyanin and promethazine were given orally 1h
before the challenge. Each value represents the mean of five
animals. * p < 0.05, statistically significant with respect to the
controls (histamine and compound 48/80).
FIG. 2. Effect  of phycocyanin on compound 48/80-induced
histamine release from rat peritoneal mast cells. Rat perito-
neal mast cells were pre-incubated at 37°C for 10min with
three different concentrations of phycocyanin and stimulated
for  a  further  5min  with  compound  48/80  (1mg/ml).  Each
value is the mean ± SEM of three experiments performed in
duplicate.  Significantly  different  from  the  control  at  p <
0.05.contain pre-formed stores of cytokines, such as tumor
necrosis factor-alpha (TNF-a) and vascular permeabil-
ity  factor/vascular  endothelial  cell  growth  factor
among others, that can be released in immunoglobu-
lin  E  (IgE)-dependent  reactions  and  can  provide  a
potential  effector  and  immunoregulatory  roles  to
mast cells in allergic inflammatory response.14Also, it
is  important  that  the  participation  of  the  newly
synthesized lipid mediators from mast cells such as
prostaglandin  D2,  leukotrienes  (LTC4,  LTD4,  LTE4,
LTB4) and platelet-activating factor (PAF), as well as
ROS, are strongly involved in IgE-dependent allergic
inflammation.14,15
In  previous  studies,  we  have  demonstrated  the
antioxidant and anti-inflammatory properties of phy-
cocyanin in various in vitro and in vivo experimental
models.1,16–18 It was thus also shown that phycocya-
nin extract reduces LTB4 and prostaglandin E2 levels
in the arachidonic acid-induced mouse ear inflamma-
tion test.2,3
In the present work, we have found that phycocya-
nin also exerts an anti-inflammatory effect in mouse
ear  swelling  response  to  ovalbumin  in  which  the
various mediators quoted earlier are released in a IgE-
mediated reaction in sensitized mice (Table 1).
In  this  test,  ear  edema  and  MPO  activity  were
reduced by phycocyanin. MPO is an enzyme present
in neutrophils and at a much lower concentration in
monocyte and macrophages. It is well known that the
level of MPO activity is directly proportional to the
neutrophil concentration on the inflamed tissue,8 by
which measurement of the enzyme activity has been
considered  a  quantitative  and  sensitive  marker  of
chemotaxis and neutrophil infiltration in the inflam-
matory  process. Therefore,  the  inhibitory  effect  of
phycocyanin on MPO activity in ovalbumin-induced
ear edema in mice constitutes further evidence of the
anti-chemoattractant action of the biliprotein because
previously  we  demonstrated  that,  in  acetic  acid-
induced colitis in the rat, phycocyanin also reduced
MPO activity in  colonic tissue, and the histological
findings also showed a substantial decrease in  neu-
trophil infiltration in colonic mucosal injury.18
In our opinion the mechanism by which phycocya-
nin exerts its anti-chemoattractant action is through
inhibitory  effects  on  the  biosynthesis  of  the  neu-
trophil  chemotactic  mediator  LTB4.  This  view  is
supported by our previous findings that phycocyanin
reduced LTB4 levels in the arachidonic acid-induced
mouse ear inflammation test.3
To elucidate whether phycocyanin is able to inhibit
histamine release, we used the rat skin reaction test to
histamine and compound 48/80 as well as the in vitro
method of histamine release induced by compound
48/80 from isolated rat mast cells.
Promethazine (an H1-receptor antagonist), and to a
lesser extent phycocyanin, inhibited skin reactions to
histamine and compound 48/80, respectively (Fig. 1).
Through this observation, the possibility of phycocya-
nin  or its metabolites interacting with H1-receptors
must  be considered, although this cannot be  eluci-
dated with this kind of experiment and will require
further studies with the use of other methods such as
radioligands.
On the contrary, the inhibitory effect of phycocya-
nin on histamine release from isolated rat mast cells
(Fig. 2) supports the involvement of this event in the
mode of action of the biliprotein as an anti-inflamma-
tory agent, and particularly in the allergic reactions of
the immediate type triggered by IgE.
At the present time, evidence is available that ROS
such  as  superoxide  anion,  hydrogen  peroxide,
hydroxyl and peroxyl radicals may initiate the arachi-
donic  acid  cascade,  PAF  synthesis  or  histamine
release.19–22Thus, it has been demonstrated that ROS
degranulate mast cells leading to release of histamine,
serotonin,  TNF-aand other mediators of inflammation.
Furthermore, evidence has been provided that hista-
mine is a marker of OH￿radicals.23Phycocyanin is able
to scavenge hydroxyl, alkoxy and peroxyl radicals.1,24
Taking together the presented results, it is conceiv-
able  that  these  ROS  scavenging  properties  of  the
biliprotein  may  explain  its  inhibitory  effects  on
histamine release and other mediators of inflamma-
tion. However, further experiments are required  to
confirm  whether  ROS  and  other  intracellular  mes-
sengers  such  as  cAMP  and  intracellular  calcium25
might be involved in the inhibitory effect of phyco-
cyanin on histamine release from rat mast cells.
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